Page last updated: 2024-09-05

eslicarbazepine acetate and Abdominal Epilepsy

eslicarbazepine acetate has been researched along with Abdominal Epilepsy in 46 studies

Research

Studies (46)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (10.87)29.6817
2010's34 (73.91)24.3611
2020's7 (15.22)2.80

Authors

AuthorsStudies
Hirsch, M; Immisch, I; Knake, S; Schulze-Bonhage, A1
Auvin, S; Falcão, AC; Gama, H; Kirkham, F; Moreira, J; Rocha, JF; Soares-da-Silva, P1
Ley, M; Principe, A; Rocamora, R1
Chaves, J; Ikedo, F; Moreira, J; Rocamora, R; Soares-da-Silva, P; Trinka, E1
Aparicio, J; García-Peñas, JJ; Roldán-Aparicio, S; Smeyers-Durá, P1
Fernández-Anaya, S; Rico-Villademoros, F; Rojo, R; Sarasa, P; Serratosa, JM; Villanueva, V1
Chang, XC; Hong, WK; Wang, Y; Xu, HQ; Yuan, H; Zheng, RY1
Camacho, JL; Castillo, A; Garcés, M; Giner, P; Giráldez, BG; Gómez-Ibáñez, A; Guillamón, E; López-Gomáriz, E; López-González, FJ; Mauri, JA; Molins, A; Palau, J; Rodríguez-Uranga, J; Salas-Puig, J; Serratosa, JM; Toledo, M; Torres, N; Villanueva, V1
Abou-Khalil, B; Biton, V; Blum, D; Cheng, H; Elger, CE; Gama, H; Grinnell, T; Krauss, G; Moreira, J; Rocha, JF; Rogin, JB; Trinka, E1
Galiana, GL; Gauthier, AC; Mattson, RH1
Cagnetti, C; Foschi, N; Lattanzi, S; Lorusso, A; Provinciali, L; Silvestrini, M1
Arjona-Padillo, A; Bertol-Alegre, V; Estévez-María, JC; Fernández-Pérez, J; Galván-Espinosa, J; García-Martínez, A; López-González, FJ; Maestre-Moreno, JF; Mauri-Llerda, JA; Molto-Jorda, JM; Payán-Ortiz, M; Querol-Pascual, R; Ruiz-Giménez, J; Serrano-Castro, PJ; Toledo-Argany, M; Tortosa-Conesa, D1
Andersen, NB; Nielsen, MK; Petrenaite, V1
Paule, E; Rosenow, F; Schubert-Bast, S; Strzelczyk, A; Willems, LM; Zöllner, JP1
Ben-Menachem, E; Elger, C; Keller, B; Kowacs, PA; Löffler, K; Rocha, JF; Soares-da-Silva, P; Trinka, E1
Brigo, F; Cagnetti, C; Grillo, E; Lattanzi, S; Silvestrini, M; Verrotti, A; Zaccara, G1
Abraira, L; Ortega, G; Quintana, M; Salas-Puig, J; Sanabria, A; Santamarina, E; Toledo, M1
Cimadevilla, JM; Fernández-Pérez, J; Payán-Ortiz, M; Quiroga-Subirana, P; Serrano-Castro, PJ1
Keating, GM1
Chaves, J; Correia, FD; Freitas, J; Lopes, J; Lopes-Lima, J; Magalhães, R; Ramalheira, J1
Buchneva, IA; Ermolenko, NA1
Blum, D; Cheng, H; Grinnell, T; Harvey, J; Sperling, MR1
Banach, M; Borowicz, KK; Czuczwar, SJ1
Bhatia, P; Blum, D; Cheng, H; Grinnell, T; Jacobson, MP; Pazdera, L1
Brodie, MJ1
Anastassopoulos, KP; Blum, D; Bond, TC; Cramer, JA; Gilliam, FG; Moreira, J; Rocha, F; Ryvlin, P; Specchio, LM; Velez, FF; Wang, X1
Bagul, M; Holtkamp, M; Kockelmann, E; McMurray, R; Sousa, R1
Dhillon, S; Shirley, M1
Ben-Menachem, E; Zelano, J1
Bragazzi, NL; Brigo, F; Nardone, R; Trinka, E1
Bermejo, P; Bonet, M; Camacho, JL; Campos, D; Galiano, ML; Garcés, M; Giner, P; Gómez-Ibáñez, A; López-González, FJ; Martínez, P; Massot-Tarrús, A; Mauri, JA; Montoya, J; Ojeda, J; Poza, JJ; Rodriguez-Osorio, X; Rodríguez-Uranga, J; Ruiz-Giménez, J; Toledo, M; Vilella, L; Villanueva, V; Zurita, J1
Ben-Menachem, E; Holtkamp, M; Peltola, J; Shorvon, SD; Steinhoff, BJ; Trinka, E; Villanueva, V1
Breia, P; Carvalho, M; Chaves, J; Fernandes, H; Gala, A; Grebe, H; Mateus, P; Mestre, A; Pelejão, R; Pimentel, J; Sousa, R1
Anastassopoulos, KP; Blum, D; Bond, TC; Cramer, JA; Sousa, R; Velez, FF; Wang, X1
McCormack, PL; Robinson, DM1
Ferreira, J; Mestre, T1
Almeida, L; Elger, C; Halász, P; Maia, J; Soares-da-Silva, P1
Almeida, L; Gil-Nagel, A; Lopes-Lima, J; Maia, J; Soares-da-Silva, P1
Owen, RT1
Almeida, L; Ben-Menachem, E; Gabbai, AA; Hufnagel, A; Maia, J; Soares-da-Silva, P1
Almeida, L; Cramer, JA; Członkowska, A; Elger, C; Guekht, A; Halász, P; Hodoba, D; Maia, J; Soares-da-Silva, P1
Luef, G; Rauchenzauner, M1
Chang, XC; Wang, Y; Xu, HQ; Yuan, H; Zheng, RY1
Almeida, L; Ben-Menachem, E; Falcão, A; Gabbai, AA; Hufnagel, A; Soares-da-Silva, P1
Almeida, L; Ben-Menachem, E; da-Silva, PS; Elger, C; Falcão, A; Gabbai, AA; Gil-Nagel, A; Halász, P; Lopes-Lima, J; Nunes, T1
Almeida, L; Bialer, M; Cramer, JA; Elger, C; Maia, J; Soares-da-Silva, P1

Reviews

19 review(s) available for eslicarbazepine acetate and Abdominal Epilepsy

ArticleYear
[The role of eslicarbazepine acetate in the treatment of focal-onset epilepsy in pediatric age: practical issues].
    Revista de neurologia, 2020, Nov-10, Volume: 71, Issue:s01

    Topics: Adolescent; Anticonvulsants; Child; Dibenzazepines; Epilepsies, Partial; Humans

2020
Initial monotherapy with eslicarbazepine acetate for the management of adult patients with focal epilepsy in clinical practice: a meta-analysis of observational studies.
    The International journal of neuroscience, 2023, Volume: 133, Issue:4

    Topics: Adult; Anticonvulsants; Dibenzazepines; Epilepsies, Partial; Humans; Randomized Controlled Trials as Topic; Retrospective Studies; Treatment Outcome

2023
Eslicarbazepine acetate add-on therapy for drug-resistant focal epilepsy.
    The Cochrane database of systematic reviews, 2021, 06-22, Volume: 6

    Topics: Adolescent; Adult; Age Factors; Aged; Anticonvulsants; Bias; Child; Dibenzazepines; Drug Resistant Epilepsy; Drug Therapy, Combination; Epilepsies, Partial; Humans; Intention to Treat Analysis; Middle Aged; Randomized Controlled Trials as Topic; Withholding Treatment; Young Adult

2021
Adjunctive eslicarbazepine acetate: A pooled analysis of three phase III trials.
    Epilepsy & behavior : E&B, 2017, Volume: 72

    Topics: Adolescent; Adult; Anticonvulsants; Clinical Trials, Phase III as Topic; Dibenzazepines; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Epilepsies, Partial; Female; Humans; Internationality; Male; Randomized Controlled Trials as Topic; Treatment Outcome; Voltage-Gated Sodium Channel Blockers; Young Adult

2017
Eslicarbazepine Acetate: A New Improvement on a Classic Drug Family for the Treatment of Partial-Onset Seizures.
    Drugs in R&D, 2017, Volume: 17, Issue:3

    Topics: Animals; Anticonvulsants; Cytochrome P-450 CYP2C19; Dibenzazepines; Drug Interactions; Epilepsies, Partial; Humans; Voltage-Gated Sodium Channel Blockers

2017
Eslicarbazepine acetate in epilepsies with focal and secondary generalised seizures: systematic review of current evidence.
    Expert review of clinical pharmacology, 2018, Volume: 11, Issue:3

    Topics: Adolescent; Adult; Anticonvulsants; Child; Dibenzazepines; Drug Interactions; Drug Monitoring; Epilepsies, Partial; Epilepsy, Generalized; Humans; Sodium

2018
Adjunctive Eslicarbazepine Acetate in Pediatric Patients with Focal Epilepsy: A Systematic Review and Meta-Analysis.
    CNS drugs, 2018, Volume: 32, Issue:3

    Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Dibenzazepines; Epilepsies, Partial; Humans; Pediatrics; Randomized Controlled Trials as Topic

2018
Eslicarbazepine acetate: a review of its use as adjunctive therapy in refractory partial-onset seizures.
    CNS drugs, 2014, Volume: 28, Issue:7

    Topics: Administration, Oral; Adult; Anticonvulsants; Dibenzazepines; Epilepsies, Partial; Humans; Voltage-Gated Sodium Channel Blockers

2014
[Exalief as a newer antiepileptic drug for adjunctive therapy of refractory partial-onset seizures].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2014, Volume: 114, Issue:11

    Topics: Anticonvulsants; Clinical Trials, Phase III as Topic; Dibenzazepines; Epilepsies, Partial; Humans; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Voltage-Gated Sodium Channel Blockers

2014
Pharmacokinetic/pharmacodynamic evaluation of eslicarbazepine for the treatment of epilepsy.
    Expert opinion on drug metabolism & toxicology, 2015, Volume: 11, Issue:4

    Topics: Adult; Age Factors; Animals; Anticonvulsants; Carbamazepine; Child; Dibenzazepines; Dose-Response Relationship, Drug; Drug Therapy, Combination; Epilepsies, Partial; Humans; Oxcarbazepine

2015
Practical Use of Newer Antiepileptic Drugs as Adjunctive Therapy in Focal Epilepsy.
    CNS drugs, 2015, Volume: 29, Issue:11

    Topics: Acetamides; Adult; Aged; Animals; Anticonvulsants; Carbamates; Dibenzazepines; Drug Resistant Epilepsy; Epilepsies, Partial; Female; Humans; Lacosamide; Male; Middle Aged; Nitriles; Phenylenediamines; Pyridones

2015
Eslicarbazepine Acetate Monotherapy: A Review in Partial-Onset Seizures.
    Drugs, 2016, Volume: 76, Issue:6

    Topics: Administration, Oral; Anticonvulsants; Dibenzazepines; Epilepsies, Partial; Humans; Seizures

2016
Efficacy and tolerability of brivaracetam compared to lacosamide, eslicarbazepine acetate, and perampanel as adjunctive treatments in uncontrolled focal epilepsy: Results of an indirect comparison meta-analysis of RCTs.
    Seizure, 2016, Volume: 42

    Topics: Acetamides; Anticonvulsants; Dibenzazepines; Drug Therapy, Combination; Epilepsies, Partial; Humans; Lacosamide; Nitriles; Pyridones; Pyrrolidinones; Randomized Controlled Trials as Topic

2016
Eslicarbazepine acetate: its effectiveness as adjunctive therapy in clinical trials and open studies.
    Journal of neurology, 2017, Volume: 264, Issue:3

    Topics: Anticonvulsants; Clinical Trials, Phase III as Topic; Dibenzazepines; Drug Substitution; Epilepsies, Partial; Humans; Randomized Controlled Trials as Topic; Seizures

2017
Eslicarbazepine acetate.
    CNS drugs, 2009, Volume: 23, Issue:1

    Topics: Animals; Dibenzazepines; Dose-Response Relationship, Drug; Epilepsies, Partial; Humans; Sodium Channel Blockers

2009
Eslicarbazepine acetate: a new option for the treatment of focal epilepsy.
    Expert opinion on investigational drugs, 2009, Volume: 18, Issue:2

    Topics: Animals; Anticonvulsants; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dibenzazepines; Epilepsies, Partial; Humans; Treatment Outcome

2009
Eslicarbazepine acetate: A novel agent for the adjunctive treatment of epilepsy.
    Drugs of today (Barcelona, Spain : 1998), 2010, Volume: 46, Issue:1

    Topics: Animals; Anticonvulsants; Clinical Trials as Topic; Dibenzazepines; Drug Interactions; Epilepsies, Partial; Humans; Sodium Channel Blockers

2010
Eslicarbazepine acetate for partial-onset seizures.
    Expert review of neurotherapeutics, 2011, Volume: 11, Issue:12

    Topics: Anticonvulsants; Dibenzazepines; Dose-Response Relationship, Drug; Drug Interactions; Epilepsies, Partial; Humans; Treatment Outcome

2011
Eslicarbazepine acetate add-on for drug-resistant partial epilepsy.
    The Cochrane database of systematic reviews, 2011, Dec-07, Issue:12

    Topics: Adult; Aged; Anticonvulsants; Dibenzazepines; Drug Resistance; Drug Therapy, Combination; Epilepsies, Partial; Humans; Middle Aged; Randomized Controlled Trials as Topic; Young Adult

2011

Trials

17 trial(s) available for eslicarbazepine acetate and Abdominal Epilepsy

ArticleYear
Efficacy and safety of eslicarbazepine acetate as adjunctive therapy for refractory focal-onset seizures in children: A double-blind, randomized, placebo-controlled, parallel-group, multicenter, phase-III clinical trial.
    Epilepsy & behavior : E&B, 2020, Volume: 105

    Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Dibenzazepines; Double-Blind Method; Drug Therapy, Combination; Epilepsies, Partial; Female; Humans; Male; Treatment Outcome

2020
Long-term efficacy and safety of eslicarbazepine acetate monotherapy for adults with newly diagnosed focal epilepsy: An open-label extension study.
    Epilepsia, 2020, Volume: 61, Issue:10

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Dibenzazepines; Double-Blind Method; Epilepsies, Partial; Female; Humans; Male; Middle Aged; Time Factors; Treatment Outcome; Young Adult

2020
Efficacy and safety of eslicarbazepine acetate versus controlled-release carbamazepine monotherapy in newly diagnosed epilepsy: A phase III double-blind, randomized, parallel-group, multicenter study.
    Epilepsia, 2018, Volume: 59, Issue:2

    Topics: Adult; Alanine Transaminase; Anticonvulsants; Carbamazepine; Delayed-Action Preparations; Dibenzazepines; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Epilepsies, Partial; Equivalence Trials as Topic; Fatigue; Female; gamma-Glutamyltransferase; Headache; Humans; Logistic Models; Male; Middle Aged; Nausea; Treatment Outcome; Voltage-Gated Sodium Channel Blockers; Young Adult

2018
[Social cognition and cognitive functions in patients with epilepsy treated with eslicarbazepine acetate].
    Revista de neurologia, 2018, Jun-01, Volume: 66, Issue:11

    Topics: Adult; Anticonvulsants; Anxiety; Cognition; Depression; Dibenzazepines; Dose-Response Relationship, Drug; Emotional Intelligence; Epilepsies, Partial; Executive Function; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Prospective Studies; Quality of Life; Theory of Mind; Verbal Learning

2018
[Eslicarbazepine acetate in clinical practice. Efficacy and safety results].
    Revista de neurologia, 2013, Mar-16, Volume: 56, Issue:6

    Topics: Acetamides; Adolescent; Adult; Aged; Anticonvulsants; Cognition Disorders; Depression; Dibenzazepines; Drug Therapy, Combination; Epilepsies, Partial; Epilepsy; Epilepsy, Generalized; Female; Follow-Up Studies; Humans; Lacosamide; Male; Middle Aged; Sodium Channel Blockers; Weight Gain; Young Adult

2013
Efficacy and safety of conversion to monotherapy with eslicarbazepine acetate in adults with uncontrolled partial-onset seizures: a randomized historical-control phase III study based in North America.
    Epilepsia, 2015, Volume: 56, Issue:4

    Topics: Adolescent; Adult; Aged; Anticonvulsants; Dibenzazepines; Double-Blind Method; Drug Substitution; Epilepsies, Partial; Female; Humans; Male; Middle Aged; North America; Treatment Outcome; Young Adult

2015
Efficacy and safety of conversion to monotherapy with eslicarbazepine acetate in adults with uncontrolled partial-onset seizures: a historical-control phase III study.
    BMC neurology, 2015, Mar-28, Volume: 15

    Topics: Adolescent; Adult; Aged; Anticonvulsants; Dibenzazepines; Double-Blind Method; Epilepsies, Partial; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Seizures; Treatment Outcome; Young Adult

2015
Severity and burden of partial-onset seizures in a phase III trial of eslicarbazepine acetate.
    Epilepsy & behavior : E&B, 2015, Volume: 53

    Topics: Adult; Aged; Anticonvulsants; Cost of Illness; Dibenzazepines; Double-Blind Method; Epilepsies, Partial; Female; Follow-Up Studies; Humans; Male; Middle Aged; Seizures; Severity of Illness Index; Surveys and Questionnaires

2015
Real-world data on eslicarbazepine acetate as add-on to antiepileptic monotherapy.
    Acta neurologica Scandinavica, 2016, Volume: 134, Issue:1

    Topics: Adult; Anticonvulsants; Dibenzazepines; Drug Therapy, Combination; Epilepsies, Partial; Europe; Female; Humans; Male; Middle Aged; Prospective Studies; Quality of Life; Treatment Outcome; Young Adult

2016
Impact of seizure frequency reduction on health-related quality of life among clinical trial subjects with refractory partial-onset seizures: A pooled analysis of phase III clinical trials of eslicarbazepine acetate.
    Epilepsy & behavior : E&B, 2017, Volume: 68

    Topics: Adult; Anticonvulsants; Dibenzazepines; Double-Blind Method; Epilepsies, Partial; Female; Humans; Male; Mental Health; Middle Aged; Quality of Life; Seizures; Treatment Outcome

2017
Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: a randomized, double-blind, placebo-controlled, parallel-group phase III study.
    Epilepsia, 2009, Volume: 50, Issue:3

    Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Anticonvulsants; Dibenzazepines; Dose-Response Relationship, Drug; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Epilepsies, Partial; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Treatment Outcome; Young Adult

2009
Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures.
    Acta neurologica Scandinavica, 2009, Volume: 120, Issue:5

    Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Anticonvulsants; Dibenzazepines; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Epilepsies, Partial; Female; Headache; Humans; Male; Middle Aged; Nausea; Patient Selection; Placebos; Seizures; Treatment Outcome

2009
Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsy.
    Epilepsy research, 2010, Volume: 89, Issue:2-3

    Topics: Adult; Anticonvulsants; Dibenzazepines; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Synergism; Epilepsies, Partial; Female; Headache; Humans; Male; Middle Aged; Nausea; Seizures; Treatment Outcome

2010
Long-term efficacy and safety of eslicarbazepine acetate: results of a 1-year open-label extension study in partial-onset seizures in adults with epilepsy.
    Epilepsia, 2010, Volume: 51, Issue:10

    Topics: Adolescent; Adult; Aged; Anticonvulsants; Dibenzazepines; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Epilepsies, Partial; Epilepsy; Female; Health Status; Humans; Intention to Treat Analysis; Longitudinal Studies; Male; Middle Aged; Quality of Life; Surveys and Questionnaires; Treatment Outcome

2010
Long-term safety and efficacy of eslicarbazepine acetate as adjunctive therapy in the treatment of partial-onset seizures in adults with epilepsy: results of a 1-year open-label extension study.
    Epilepsy research, 2013, Volume: 103, Issue:2-3

    Topics: Adolescent; Adult; Aged; Anticonvulsants; Dibenzazepines; Double-Blind Method; Drug Therapy, Combination; Epilepsies, Partial; Epilepsy; Female; Humans; Male; Middle Aged; Time Factors; Treatment Outcome; Young Adult

2013
Efficacy and safety of eslicarbazepine acetate as add-on treatment in patients with focal-onset seizures: integrated analysis of pooled data from double-blind phase III clinical studies.
    Epilepsia, 2013, Volume: 54, Issue:1

    Topics: Adult; Anticonvulsants; Dibenzazepines; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Epilepsies, Partial; Female; Humans; Male

2013
Eslicarbazepine acetate: a double-blind, add-on, placebo-controlled exploratory trial in adult patients with partial-onset seizures.
    Epilepsia, 2007, Volume: 48, Issue:3

    Topics: Adolescent; Adult; Anticonvulsants; Dibenzazepines; Disease-Free Survival; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Epilepsies, Partial; Female; Humans; Male; Middle Aged; Placebos; Treatment Outcome

2007

Other Studies

10 other study(ies) available for eslicarbazepine acetate and Abdominal Epilepsy

ArticleYear
A Prospective Longitudinal Study of the Effects of Eslicarbazepine Acetate Treatment on Bone Density and Metabolism in Patients with Focal-Onset Epilepsy.
    CNS drugs, 2023, Volume: 37, Issue:11

    Topics: Adult; Anticonvulsants; Bone Density; Bone Diseases, Metabolic; Dibenzazepines; Epilepsies, Partial; Epilepsy; Female; Humans; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Treatment Outcome

2023
[Long-term effects of dibenzazepines on metabolic parameters: retrospective comparison of carbamazepine, oxcarbazepine and eslicarbazepine acetate in the real world].
    Revista de neurologia, 2020, Jul-16, Volume: 71, Issue:2

    Topics: Adult; Aged; Alanine Transaminase; Anticonvulsants; Aspartate Aminotransferases; Carbamazepine; Dibenzazepines; Epilepsies, Partial; Female; Follow-Up Studies; gamma-Glutamyltransferase; Healthy Lifestyle; Humans; Hyponatremia; Leukocyte Count; Lipids; Male; Metabolism; Middle Aged; Nerve Tissue Proteins; Oxcarbazepine; Retrospective Studies; Sodium; Voltage-Gated Sodium Channels

2020
Efficacy and safety of eslicarbazepine-acetate in elderly patients with focal epilepsy: Case series.
    Seizure, 2017, Volume: 48

    Topics: Aged; Aged, 80 and over; Anticonvulsants; Dibenzazepines; Epilepsies, Partial; Female; Humans; Male; Retrospective Studies; Treatment Outcome

2017
Eslicarbazepine acetate as adjunctive treatment in partial-onset epilepsy.
    Acta neurologica Scandinavica, 2018, Volume: 137, Issue:1

    Topics: Adult; Anticonvulsants; Carbamazepine; Dibenzazepines; Drug Therapy, Combination; Epilepsies, Partial; Female; Humans; Male; Middle Aged; Oxcarbazepine; Retrospective Studies; Seizures; Young Adult

2018
Eslicarbazepine acetate and carotid intima-media thickness in epileptic patients.
    Epilepsy research, 2017, Volume: 138

    Topics: Adolescent; Adult; Aged; Carotid Intima-Media Thickness; Dibenzazepines; Epilepsies, Partial; Female; Humans; Hypertension; Male; Middle Aged; Retrospective Studies; Statistics, Nonparametric; Ultrasonography; Voltage-Gated Sodium Channel Blockers; Young Adult

2017
Clinical experience with eslicarbazepine acetate in adults with sub-analysis of elderly.
    Seizure, 2017, Volume: 53

    Topics: Adult; Age Factors; Aged; Anticonvulsants; Carbamazepine; Dibenzazepines; Drug Therapy, Combination; Epilepsies, Partial; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Retrospective Studies; Voltage-Gated Sodium Channel Blockers; Young Adult

2017
Two-year follow-up with eslicarbazepine acetate: a consecutive, retrospective, observational study.
    Epilepsy research, 2014, Volume: 108, Issue:8

    Topics: Adult; Dibenzazepines; Epilepsies, Partial; Female; Follow-Up Studies; Humans; Male; Middle Aged; Retrospective Studies; Time Factors; Voltage-Gated Sodium Channel Blockers; Young Adult

2014
Eslicarbazepine acetate for the treatment of partial epilepsy.
    Expert opinion on pharmacotherapy, 2016, Volume: 17, Issue:8

    Topics: Dibenzazepines; Disease Management; Epilepsies, Partial; Humans

2016
EARLY-ESLI study: Long-term experience with eslicarbazepine acetate after first monotherapy failure.
    Acta neurologica Scandinavica, 2017, Volume: 136, Issue:3

    Topics: Adult; Aged; Anticonvulsants; Dibenzazepines; Dizziness; Epilepsies, Partial; Female; Humans; Hyponatremia; Male; Middle Aged; Retrospective Studies; Vertigo

2017
Eslicarbazepine acetate as adjunctive therapy in clinical practice: ESLADOBA study.
    Acta neurologica Scandinavica, 2017, Volume: 136, Issue:5

    Topics: Adult; Anticonvulsants; Dibenzazepines; Drug Therapy, Combination; Epilepsies, Partial; Female; Humans; Male; Middle Aged; Prospective Studies; Treatment Outcome

2017